κ-Opioid tolerance and dependence in cultures of dopaminergic midbrain neurons

Journal of Neuroscience

Volumn 19, Issue 14, 1999, Pages 5750-5757

  Dalman, Friedrich C ^a   O'Malley, Karen L ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Dependence; Dopaminergic neurons; Mesencephalon; Neurotransmitter release; Primary neuronal culture; Tolerance; U69,593; opioid receptor

Indexed keywords

6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; DOPAMINE; KAPPA OPIATE RECEPTOR ANTAGONIST; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; NORBINALTORPHIMINE; OPIATE DERIVATIVE; PERTUSSIS TOXIN; TETRODOTOXIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; DRUG TOLERANCE; EMBRYO; MESENCEPHALON; NERVE CELL CULTURE; NONHUMAN; OPIATE ADDICTION; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 0033565855     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.19-14-05750.1999     Document Type: Article

References (43)

1. Bhargava HN, Gulati A, Ramarao P (1989) Effect of chronic administration of U-50,488H on tolerance to its pharmacological actions and on multiple opioid receptors in rat brain regions and spinal cord. J Pharmacol Exp Ther 251:21-26.
2. Brent PJ, Chahl LA, Cantarell PA, Kavanagh C (1993) The κ-opioid receptor agonist U50,488H induces acute physical dependence in guinea-pigs. Eur J Pharmacol 241:149-156.
3. Carlezon JW, Thome J, Olson VG, Lane-Ladd SB, Brodkin ES, Hiroi N, Duman RS, Neve RL, Nestler EJ (1998) Regulation of cocaine reward by CREB. Science 282:2272-2275.
4. Chavkin C, Goldstein A (1984) Opioid receptor reserve in normal and morphine-tolerant guinea pig ileum myenteric plexus. Proc Natl Acad Sci USA 81:7253-7257.
5. Cole RL, Konradi C, Douglass J, Hyman SE (1995) Neuronal adaptation to amphetamine and dopamine: molecular mechanisms of prodynorphin gene regulation in rat striatum. Neuron 14:813-823.
6. Cox BM, Chavkin C (1983) Comparison of dynorphin-selective κ receptors in mouse vas deferens and guinea pig ileum. Spare receptor fraction as a determinant of potency. Mol Pharmacol 23:36-43.
7. Di Chiara G, Imperato A (1988) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 85:5274-5278.
8. Donzanti BA, Althaus JS, Payson MM, Von Voigtlander PF (1992) κ-Agonist-induced reduction in dopamine release: site of action and tolerance. Res Commun Chem Pathol Pharmacol 78:193-210.
9. Feng Y, Rockhold RW, Ho IK (1997) Norbinaltorphimine precipitates withdrawal and excitatory amino acid release in the locus ceruleus of butorphanol-but not morphine-dependent rats. J Pharmacol Exp Ther 283:932-938.
10. Freedman NJ, Lefkowitz RJ (1996) Desensitization of G-protein-coupled receptors. Recent Prog Horm Res 51:319-51:319-351.
11. Glick SD, Maisonneuve IM, Raucci J, Archer S (1995) κ-Opioid inhibition of morphine and cocaine self-administration in rats. Brain Res 681:147-152.
12. Gmerek DE, Woods JH (1986) κ-Receptor-mediated opioid dependence in rhesus monkeys. Life Sci 39:987-992.
13. Gmerek DE, Dykstra LA, Woods JH (1987) κ Opioids in rhesus monkeys. III. Dependence associated with chronic administration. J Pharmacol Exp Ther 242:428-436.
14. Heidbreder CA, Goldberg SR, Shippenberg TS (1993) The κ-opioid receptor agonist U-69593 attenuates cocaine-induced behavioral sensitization in the rat. Brain Res 616:335-338.
15. Heidbreder CA, Babovic-Vuksanovic D, Shoaib M, Shippenberg TS (1995) Development of behavioral sensitization to cocaine: influence of κ-opioid receptor agonists. J Pharmacol Exp Ther 275:150-163.
16. Hurd YL, Herkenham M (1993) Molecular alterations in the neostriatum of human cocaine addicts. Synapse 13:357-369.
17. Hyman SE (1996) Addiction to cocaine and amphetamine. Neuron 16:901-904.
18. Jin W, Terman GW, Chavkin C (1997) κ-Opioid receptor tolerance in the guinea pig hippocampus. J Pharmacol Exp Ther 281:123-128.
19. Koob GF, Le Moal M (1997) Drug abuse: hedonic homeostatic dysregulation. Science 278:52-58.
20. Kuhar MJ, Vaughan R, Uhl G, Cerruti C, Revay R, Freed C, Nirenburg M, Pickel V (1998) Localization of dopamine transporter protein by microscopic histochemistry. Adv Pharmacol 42:168-170.
21. Loh HH, Tao PL, Smith AP (1988) Role of receptor regulation in opioid tolerance mechanisms. Synapse 2:457-462.
22. Martin WR, Gorodetzky CW, McClane TK (1966) An experimental study in the treatment of narcotic addicts with cyclazocine. Clin Pharmacol Ther 7:455-465.
23. Mello NK, Negus SS (1998) Effects of κ-opioid agonists on cocaine-and food-maintained responding by rhesus monkeys. J Pharmacol Exp Ther 286:812-824.
24. Milanes MV, Rabadan JV, Laorden ML (1997) Effects of chronic U-50,488H treatment on the isolated right atrium of the rat. Neuropeptides 31:511-515.
25. Negus SS, Mello NK, Portoghese PS, Lin CE (1997) Effects of κ opioids on cocaine self-administration by rhesus monkeys. J Pharmacol Exp Ther 282:44-55.
26. Nestler EJ, Aghajanian GK (1997) Molecular and cellular basis of addiction. Science 278:58-63.
27. O'Malley KL, Mack KJ, Gandehnan KY, Todd RD (1990) Organization and expression of the rat D2A receptor gene: identification of alternative transcripts and a variant donor splice site. Biochemistry 29:1367-1371.
28. Paronis CA, Woods JH (1997) Ventilation in morphine-maintained rhesus monkeys. II. Tolerance to the antinociceptive but not the ventilatory effects of morphine. J Pharmacol Exp Ther 282:355-362.
29. Portoghese PS, Lipkowski AW, Takemori AE (1987) Binaltorphimine and nor-binaltorphimine, potent and selective κ-opioid receptor antagonists. Life Sci 40:1287-1292.
30. Reece PA, Sedman AJ, Rose S, Wright DS, Dawkins R, Rajagopalan R (1994) Diuretic effects, pharmacokinetics, and safety of a new centrally acting κ-opioid agonist (CI-977) in humans. J Clin Pharmacol 34:1126-1132.
31. Shippenberg TS, Rea W (1997) Sensitization to the behavioral effects of cocaine: modulation by dynorphin and κ-opioid receptor agonists. Pharmacol Biochem Behav 57:449-455.
32. Shippenberg TS, LeFevour A, Heidbreder C (1996) κ-Opioid receptor agonists prevent sensitization to the conditioned rewarding effects of cocaine. J Pharmacol Exp Ther 276:545-554.
33. 35S]GTPγS autoradiography in rat brain. J Neurosci 16:2684-2692.
34. Sivam SP (1989) Cocaine selectively increases striatonigral dynorphin levels by a dopaminergic mechanism. J Pharmacol Exp Ther 250:818-824.
35. Smiley PL, Johnson M, Bush L, Gibb JW, Hanson GR (1990) Effects of cocaine on extrapyramidal and limbic dynorphin systems. J Pharmacol Exp Ther 253:938-943.
36. Spanagel R, Herz A, Shippenberg TS (1990) The effects of opioid peptides on dopamine release in the nucleus accumbens: an in vivo microdialysis study. J Neurochem 55:1734-1740.
37. Spanagel R, Herz A, Shippenberg TS (1992) Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc Natl Acad Sci USA 89:2046-2050.
38. Spangler R, Unterwald EM, Kreek MJ (1993) "Binge" cocaine administration induces a sustained increase of prodynorphin mRNA in rat caudate-putamen. Brain Res Mol Brain Res 19:323-327.
39. Staley JK, Rothman RB, Rice KC, Partilla J, Mash DC (1997) κ2-Opioid receptors in limbic areas of the human brain are upregulated by cocaine in fatal overdose victims. J Neurosci 17:8225-8233.
40. Steiner H, Gerfen CR (1993) Cocaine-induced c-fos messenger RNA is inversely related to dynorphin expression in striatum. J Neurosci 13:5066-5081.
41. Unterwald EM, Rubenfeld JM, Kreek MJ (1994) Repeated cocaine administration upregulates κ and μ, but not δ, opioid receptors. Neuro-Report 5:1613-1616.
42. White FJ (1996) Synaptic regulation of mesocorticolimbic dopamine neurons. Annu Rev Neurosci 19:405-36:405-436.
43. Wise RA (1996) Neurobiology of addiction. Curr Opin Neurobiol 6:243-251.